NCT00007189

Data

{
  "briefSummary": "The purpose of this trial is to test the ability of the non-steroidal anti-inflammatory medications naproxen and celecoxib to delay or prevent the onset of AD and age-related cognitive decline.",
  "completionDate": null,
  "conditions": [
    "Alzheimer Disease"
  ],
  "enrollmentCount": 2625,
  "enrollmentType": null,
  "nctId": "NCT00007189",
  "phase": "PHASE3",
  "sponsorId": "seattle-institute-for-biomedical-and-clinical-research",
  "startDate": "2001-01",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)",
  "url": "https://clinicaltrials.gov/study/NCT00007189"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version